107 related articles for article (PubMed ID: 1179342)
1. [Experience with methylperon (Buronil) in 2 somatic nursing homes].
Rohde K
Tidsskr Nor Laegeforen; 1975 Aug; 95(23):1302-4. PubMed ID: 1179342
[No Abstract] [Full Text] [Related]
2. [Clinical effects of the butyrophenones. Floropipamide (Dipiperon), methylperon (Buronil), trifluperidol (Psicoperidol)].
Kristjansen P
Nord Psykiatr Tidsskr; 1968; 22(3):235-48. PubMed ID: 5711258
[No Abstract] [Full Text] [Related]
3. [Methylperon. (Buronil "Ferrosan"). A new butyrophenone neuroleptic].
Lingjaerde O
Tidsskr Nor Laegeforen; 1972 Jan; 92(3):192-3. PubMed ID: 5016100
[No Abstract] [Full Text] [Related]
4. [Side effects of methylperone in long-term therapy up to 8 years].
Kirkegaard G; Kirkegaard A
Arzneimittelforschung; 1974 Aug; 24(8):1115-7. PubMed ID: 4213783
[No Abstract] [Full Text] [Related]
5. Letter: Buronil in Huntington's chorea.
Mattsson B; Boman K
Lancet; 1974 Nov; 2(7892):1323. PubMed ID: 4139562
[No Abstract] [Full Text] [Related]
6. An early clinical trial of lenperone (AHR 2277), a butyrophenone, in chronic schizophrenia.
Simpson GM; Varga V
Curr Ther Res Clin Exp; 1974 May; 16(5):477-82. PubMed ID: 4209063
[No Abstract] [Full Text] [Related]
7. [Buronil in senile confusion and excitement. A double-blind study].
Norgård A; Tingsgaard P; Nielsen IL
Nord Psykiatr Tidsskr; 1967; 21(3):240-4. PubMed ID: 4871566
[No Abstract] [Full Text] [Related]
8. [Buronil and promazine therapy of patients with senile dementia. A double-blind study].
Engstrand E
Nord Psykiatr Tidsskr; 1967; 21(3):234-40. PubMed ID: 4871565
[No Abstract] [Full Text] [Related]
9. [The blood pressure lowering effect of chlorpromazine and methylperon (Buronil)].
Magner O; Moller S
Ugeskr Laeger; 1974 Apr; 136(15):809-11. PubMed ID: 4597391
[No Abstract] [Full Text] [Related]
10. [AHR-2277: a new major neuroleptic with minimal neurological side-effects].
Denber HC
Ann Med Psychol (Paris); 1973 Jan; 1(1):131-8. PubMed ID: 4723202
[No Abstract] [Full Text] [Related]
11. factors influencing response to major tranquilizer medications.
Kimbell I; Overall JE; Faibish GM; Pokorny AD
Dis Nerv Syst; 1972 Apr; 33(4):223-30. PubMed ID: 5029910
[No Abstract] [Full Text] [Related]
12. [Clinical evaluation of a butyrophenone derivative, methylperidol, in 40 cases of schizophrenia and other psychoses].
Vinci M
Osp Psichiatr; 1971; 39(2):399-407. PubMed ID: 4948707
[No Abstract] [Full Text] [Related]
13. [Sedalium in psychiatry within its tranquilizing and neuroleptic boundaries].
Volmat R; Beaudouin JL; Allers G; Vittouris N; Dufay F; Bizouard P
Encephale; 1972; 61(2):163-82. PubMed ID: 4634905
[No Abstract] [Full Text] [Related]
14. [Psychodynamic and sociodynamic changes produced by methylperidol].
Leal R
Actas Luso Esp Neurol Psiquiatr; 1969 Oct; 28(4):299-305. PubMed ID: 5394271
[No Abstract] [Full Text] [Related]
15. [Complementary neurolepsy].
Petrilowitsch N; Herzog R
Psychiatr Neurol (Basel); 1966; 151(4):195-207. PubMed ID: 5925592
[No Abstract] [Full Text] [Related]
16. A comparison of pimozide with perphenazine in the treatment of acute schizophrenic psychoses.
Svestka J; Náhunek K
Act Nerv Super (Praha); 1972; 14(2):93-4. PubMed ID: 4557145
[No Abstract] [Full Text] [Related]
17. [Clinical trial with R-3345].
Bastos O; Carvalho RG
J Bras Psiquiatr; 1970; 19(3):251-6. PubMed ID: 4949175
[No Abstract] [Full Text] [Related]
18. Experience with a new butyrophenone derivative (Buronil).
Vangtorp A; Simmelsgaard H; Mellegaard M
Acta Psychiatr Scand Suppl; 1968; 203():235-8. PubMed ID: 4881877
[No Abstract] [Full Text] [Related]
19. A pilot study of AL-1021 in chronic schizophrenic patients.
Sugerman AA
Curr Ther Res Clin Exp; 1969 Dec; 11(12):775-8. PubMed ID: 4984042
[No Abstract] [Full Text] [Related]
20. Pilot study on the use of AL-1021 in the treatment of chronic schizophrenia.
Angus JW; Go SH; Simpson GM
Curr Ther Res Clin Exp; 1969 Dec; 11(12):779-83. PubMed ID: 4984043
[No Abstract] [Full Text] [Related]
[Next] [New Search]
